$617 billion longevity biotech market takes shape
Our new report maps more than 3,000 therapeutic assets, tracing how money, pipelines and pharma appetite are now moving in step. Longevity biotech could become a $617 billion annual global market by 2045, according to a new Longevity.Technology report that maps the investment, clinical and regulator
<p>Our new report maps more than 3,000 therapeutic assets, tracing how money, pipelines and pharma appetite are now moving in step. Longevity biotech could become a $617 billion annual global market by 2045, according to a new Longevity.Technology report that maps the investment, clinical and regulator</p>